Skip to menu Skip to content Skip to footer
Dr Dave Coman
Dr

Dave Coman

Email: 

Overview

Background

David is a Consultant Paediatrician, Metabolic Physician, Clinical Geneticist and clinician researcher. His area of expertise is the diagnosis and management of children with rare diseases. David is involved in multiple ongoing research projects aimed at novel disease discovery, improved diagnostic testing and treatments for children with inherited genetic disorders. He is director of a national clinic for Ataxia Telangiectasia brashat.org.au and has recently been awarded a $2.5 million NHMRC research grant for a phase 2/3 trial for treatment of this disorder.

Availability

Dr Dave Coman is:
Available for supervision

Qualifications

  • Australian Health Practitioner Regulation Agency, Australian Health Practitioner Regulation Agency
  • Australian Medical Association, Australian Medical Association
  • Human Genetics Society of Australasia, Human Genetics Society of Australasia
  • Royal Australasian College of Physicians, Royal Australasian College of Physicians
  • Society for the Study of Inborn Errors of Metabolism, Society for the Study of Inborn Errors of Metabolism

Research impacts

David has close relationships with research colleagues both in Australia and internationally. He has multiple ongoing research projects investigating novel disease identification, the genetics of paediatric speech disorders and the development of new therapeutic possibilities for children and adults with rare diseases.

Works

Search Professor Dave Coman’s works on UQ eSpace

119 works between 2005 and 2024

81 - 100 of 119 works

2013

Journal Article

Charting a seven-year trajectory of language outcomes for a child with galactosemia

Lewis, Fiona M., Coman, David J., Syrmis, Maryann, Kilcoyne, Sarah and Murdoch, Bruce E. (2013). Charting a seven-year trajectory of language outcomes for a child with galactosemia. Journal of Developmental and Behavioral Pediatrics, 34 (6), 414-418. doi: 10.1097/DBP.0b013e31829a7be1

Charting a seven-year trajectory of language outcomes for a child with galactosemia

2013

Journal Article

Pediatric acute liver failure: etiology, outcomes, and the role of serial pediatric end-stage liver disease scores

Rajanayagam, Jeremy, Coman, David, Cartwright, David and Lewindon, Peter J. (2013). Pediatric acute liver failure: etiology, outcomes, and the role of serial pediatric end-stage liver disease scores. Pediatric Transplantation, 17 (4), 362-368. doi: 10.1111/petr.12083

Pediatric acute liver failure: etiology, outcomes, and the role of serial pediatric end-stage liver disease scores

2013

Book Chapter

Differential phonological awareness skills in children with classic galactosemia: a descriptive study of four cases

Lewis, Fiona M., Coman, David J., Syrmis, Maryanne, Kilcoyne, Sarah and Murdoch, Bruce E. (2013). Differential phonological awareness skills in children with classic galactosemia: a descriptive study of four cases. JIMD reports: case and research reports. (pp. 45-52) edited by Johannes Zschocke, K. Michael Gibson, Garry Brown, Eva Morava and Verena Peters. Dordrecht, Netherlands: Springer. doi: 10.1007/8904_2012_200

Differential phonological awareness skills in children with classic galactosemia: a descriptive study of four cases

2013

Journal Article

Fumarase deficiency in dichorionic diamniotic twins

Tregoning, S., Salter, W., Thorburn, D.R., Durkie, M., Panayi, M., Wu, J.Y., Easterbrook, A. and Coman, D.J. (2013). Fumarase deficiency in dichorionic diamniotic twins. Twin Research and Human Genetics, 16 (6), 1117-1120. doi: 10.1017/thg.2013.72

Fumarase deficiency in dichorionic diamniotic twins

2012

Journal Article

Impaired language abilities and pre-linguistic communication skills in a child with a diagnosis of galactosaemia

Lewis, Fiona M., Coman, David J., Syrmis, Maryanne, Kilcoyne, Sarah and Murdoch, Bruce E. (2012). Impaired language abilities and pre-linguistic communication skills in a child with a diagnosis of galactosaemia. Early Child Development and Care, 183 (12), 1747-1757. doi: 10.1080/03004430.2012.751101

Impaired language abilities and pre-linguistic communication skills in a child with a diagnosis of galactosaemia

2012

Journal Article

Extended newborn screening: An update for the general paediatrician

Coman, David and Bhattacharya, Kaustuv (2012). Extended newborn screening: An update for the general paediatrician. Journal of Paediatrics and Child Health, 48 (2), E68-E72. doi: 10.1111/j.1440-1754.2011.02199.x

Extended newborn screening: An update for the general paediatrician

2012

Journal Article

IgG N-glycans as potential biomarkers for determining galactose tolerance in Classical Galactosaemia

Coss, K.P., Byrne, J.C., Coman, D.J., Adamczyk, B., Abrahams, J.L., Saldova, R., Brown, A.Y., Walsh, O., Hendroff, U., Carolan, C., Rudd, P.M. and Treacy, E.P. (2012). IgG N-glycans as potential biomarkers for determining galactose tolerance in Classical Galactosaemia. Molecular Genetics and Metabolism, 105 (2), 1-9. doi: 10.1016/j.ymgme.2011.10.018

IgG N-glycans as potential biomarkers for determining galactose tolerance in Classical Galactosaemia

2012

Conference Publication

Early communicative skills in galactosaemia

Lewis, F. M., Coman, D. J., Kilcoyne, S., Syrmis, M. and Murdoch, B. E. (2012). Early communicative skills in galactosaemia. Developmental Neurorehabilitation Conference, Jasper, Canada, 15-16 December 2012.

Early communicative skills in galactosaemia

2011

Conference Publication

The emergence and development of language in infants and children with a diagnosis of galactosaemia

Coman, David J., Lewis, Fiona M., Murdoch, Bruce E. and Syrmis, Maryann (2011). The emergence and development of language in infants and children with a diagnosis of galactosaemia. 3rd Annual Australasian Clinical Metabolic Meeting, Brisbane, QLD, Australia Australia, 18-19 March 2011.

The emergence and development of language in infants and children with a diagnosis of galactosaemia

2011

Conference Publication

Stability of language skills despite marked leukoencephalopathic changes in a child with Leber Hereditary Optic Neuropathy following CNS-directed leukaemia treatment

Lewis, Fiona M, Coman, David J and Murdoch, Bruce E (2011). Stability of language skills despite marked leukoencephalopathic changes in a child with Leber Hereditary Optic Neuropathy following CNS-directed leukaemia treatment. XX World Congress of Neurology, Marrakech, Morocco, 12-17 November 2011.

Stability of language skills despite marked leukoencephalopathic changes in a child with Leber Hereditary Optic Neuropathy following CNS-directed leukaemia treatment

2011

Journal Article

Enzyme replacement therapy and extended newborn screening for mucopolysaccharidoses: opinions of treating physicians

Coman, David J., Hayes, Ian M, Collins, Veronica, Sahhar, Margaret, Wraith, J. Ed and Delatycki, Martin B (2011). Enzyme replacement therapy and extended newborn screening for mucopolysaccharidoses: opinions of treating physicians. Journal of Inherited Metabolic Disease, 1, 9-15. doi: 10.1007/8904_2011_9

Enzyme replacement therapy and extended newborn screening for mucopolysaccharidoses: opinions of treating physicians

2010

Journal Article

Language skills in a child with Leber hereditary optic neuropathy following intrathecal chemotherapy for acute lymphoblastic leukemia

Lewis, Fiona M., Coman, David J. and Murdoch, Bruce E. (2010). Language skills in a child with Leber hereditary optic neuropathy following intrathecal chemotherapy for acute lymphoblastic leukemia. Pediatric Hematology and Oncology, 27 (8), 626-635. doi: 10.3109/08880018.2010.503340

Language skills in a child with Leber hereditary optic neuropathy following intrathecal chemotherapy for acute lymphoblastic leukemia

2010

Journal Article

Enzyme replacement therapy for mucopolysaccharidosis VI from 8 weeks of age – a sibling control study

McGill, J. J., Inwood, A. C., Coman, D. J., Lipke, M. L., de Lore, D, Swiedler, S. J. and Hopwood, J. J. (2010). Enzyme replacement therapy for mucopolysaccharidosis VI from 8 weeks of age – a sibling control study. Clinical Genetics, 77 (5), 492-498. doi: 10.1111/j.1399-0004.2009.01324.x

Enzyme replacement therapy for mucopolysaccharidosis VI from 8 weeks of age – a sibling control study

2010

Journal Article

Galactosemia, a single gene disorder with epigenetic consequences

Coman, David J., Murray, David W., Byrne, Jennifer C., Rudd, Pauline M., Bagadlia, Paola M., Doran, Peter D. and Treacy, Eileen P. (2010). Galactosemia, a single gene disorder with epigenetic consequences. Pediatric Research, 67 (3), 286-292. doi: 10.1203/PDR.0b013e3181cbd542

Galactosemia, a single gene disorder with epigenetic consequences

2010

Journal Article

Three Mendelian disorders (chronic granulomatous disease, retinitis pigmentosa, ornithine transcarbamylase deficiency) in a young woman with an X chromosome deletion, del(X)(p11.4p21.1)

Coman, David, Yaplito-Lee, Joy, La, Phung, Nasioulas, Steven, Bruno, Damien, Slater, Howard R., Stock-Myer, Sharyn E., Lynch, Elly L. and Gardner, R.J. McKinlay (2010). Three Mendelian disorders (chronic granulomatous disease, retinitis pigmentosa, ornithine transcarbamylase deficiency) in a young woman with an X chromosome deletion, del(X)(p11.4p21.1). Molecular Genetics and Metabolism, 99 (3), 329. doi: 10.1016/j.ymgme.2009.11.006

Three Mendelian disorders (chronic granulomatous disease, retinitis pigmentosa, ornithine transcarbamylase deficiency) in a young woman with an X chromosome deletion, del(X)(p11.4p21.1)

2010

Journal Article

Mutations in the nuclear localization sequence of the Aristaless related homeobox; Sequestration of mutant ARX with IPO13 disrupts normal subcellular distribution of the transcription factor and retards cell division

Shoubridge, Cheryl, Tan, May, Fullston, Tod, Cloosterman, Desiree, Coman, David, McGillivray, George, Mancini, Grazia, Kleefstra, Tjitske and Gécz, Jozef (2010). Mutations in the nuclear localization sequence of the Aristaless related homeobox; Sequestration of mutant ARX with IPO13 disrupts normal subcellular distribution of the transcription factor and retards cell division. PathoGenetics, 3 (1) 1. doi: 10.1186/1755-8417-3-1

Mutations in the nuclear localization sequence of the Aristaless related homeobox; Sequestration of mutant ARX with IPO13 disrupts normal subcellular distribution of the transcription factor and retards cell division

2010

Journal Article

Trisomy 16 mosaicism at chorionic villus sampling and amniocentesis with a normal physical and intellectual outcome

Coman, D., Gardner, R. J., Pertile, M. D. and Kannu, P. (2010). Trisomy 16 mosaicism at chorionic villus sampling and amniocentesis with a normal physical and intellectual outcome. Fetal diagnosis and therapy, 28 (2), 117-118. doi: 10.1159/000316404

Trisomy 16 mosaicism at chorionic villus sampling and amniocentesis with a normal physical and intellectual outcome

2009

Journal Article

Molecular basis of EEC (ectrodactyly, ectodermal dysplasia, clefting) syndrome: Five new mutations in the DNA-binding domain of the TP63 gene and genotype–phenotype correlation

Clements, S. E., Techanukul, T., Coman, D., Mellerio, J. E. and McGrath, J.A. (2009). Molecular basis of EEC (ectrodactyly, ectodermal dysplasia, clefting) syndrome: Five new mutations in the DNA-binding domain of the TP63 gene and genotype–phenotype correlation. British Journal of Dermatology, 162 (1), 201-207. doi: 10.1111/j.1365-2133.2009.09496.x

Molecular basis of EEC (ectrodactyly, ectodermal dysplasia, clefting) syndrome: Five new mutations in the DNA-binding domain of the TP63 gene and genotype–phenotype correlation

2009

Journal Article

Detection of cryptic pathogenic copy number variations and constitutional loss of heterozygosity using high resolution SNP microarray analysis in 117 patients referred for cytogenetic analysis and impact on clinical practice

Bruno, D. L., Ganesamoorthy, D., Schoumans, J., Bankier, A., Coman, D., Delatycki, M., Gardner, R. J. M., Hunter, M., James, P. A., Kannu, P., McGillivray, G., Pachter, N., Peters, H., Rieubland, C., Savarirayan, R., Scheffer, I. E., Sheffield, L., Tan, T., White, S. M., Yeung, A., Bowman, Z., Ngo, C., Choy, K. W., Cacheux, V., Wong, L., Amor, D. J. and Slater, H. R. (2009). Detection of cryptic pathogenic copy number variations and constitutional loss of heterozygosity using high resolution SNP microarray analysis in 117 patients referred for cytogenetic analysis and impact on clinical practice. Journal of Medical Genetics, 46 (2), 123-131. doi: 10.1136/jmg.2008.062604

Detection of cryptic pathogenic copy number variations and constitutional loss of heterozygosity using high resolution SNP microarray analysis in 117 patients referred for cytogenetic analysis and impact on clinical practice

2009

Journal Article

Prenatal cardiac ultrasound finding in congenital disorder of glycosylation type 1a

Malhotra, A., Pateman, A., Chalmers, R., Coman, D. and Menahem, S. (2009). Prenatal cardiac ultrasound finding in congenital disorder of glycosylation type 1a. Fetal Diagnosis and Therapy: clinical advances and basic research, 25 (1), 54-57. doi: 10.1159/000196816

Prenatal cardiac ultrasound finding in congenital disorder of glycosylation type 1a

Funding

Current funding

  • 2024 - 2027
    Metabolic Medicine Research Clinical Trial in Ataxia-Telangiectasia
    BrAshA-T Ataxia-Telangiectasia Research Funding
    Open grant
  • 2023 - 2028
    Translational Centre for Speech Disorders (NHMRC Centre of Research Excellence administered by Murdoch Children's Research Institute)
    Murdoch Childrens Research Institute
    Open grant
  • 2021 - 2024
    Repairing catalase function in A-T patients using a CAT-SKL therapeutic
    National Stem Cell Foundation of Australia Matched Funding Program
    Open grant
  • 2021 - 2025
    Mitochondrial Diagnostic Network for Genomics and Omics - Not being led through UQ.
    Murdoch Childrens Research Institute
    Open grant
  • 2020 - 2025
    Ataxia-telangiectasia: treating mitochondrial dysfunction with a novel form of anaplerosis
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant

Past funding

  • 2020 - 2023
    A Phase 2A/2B placebo-controlled randomised clinical trial to test the ability of triheptanoin to protect primary airway epithelial cells obtained from patients with ataxia-telangiectasia against....
    BrAshA-T Ataxia-Telangiectasia Research Funding
    Open grant
  • 2020 - 2022
    Ataxia-telangiectasia: treating mitochondrial dysfunction with a novel form of anaplerosis
    Wesley Medical Research Ltd
    Open grant
  • 2011 - 2013
    Early prediction of intellectual and cognitive-linguistic outcomes in children with treated galactosaemia
    APEX Foundation for Research into Intellectual Disability Ltd (AFRID)
    Open grant

Supervision

Availability

Dr Dave Coman is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Media

Enquiries

For media enquiries about Dr Dave Coman's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au